Zacks: Brokerages Expect K2M Group Holdings, Inc. (KTWO) Will Announce Earnings of -$0.19 Per Share
Equities research analysts expect K2M Group Holdings, Inc. (NASDAQ:KTWO) to post earnings per share of ($0.19) for the current quarter, Zacks reports. Three analysts have made estimates for K2M Group Holdings’ earnings. The lowest EPS estimate is ($0.26) and the highest is ($0.14). K2M Group Holdings also reported earnings per share of ($0.19) in the same quarter last year. The company is expected to announce its next quarterly earnings report after the market closes on Wednesday, November 1st.
According to Zacks, analysts expect that K2M Group Holdings will report full-year earnings of ($0.83) per share for the current year, with EPS estimates ranging from ($0.99) to ($0.75). For the next year, analysts forecast that the business will report earnings of ($0.46) per share, with EPS estimates ranging from ($0.81) to ($0.30). Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that follow K2M Group Holdings.
K2M Group Holdings (NASDAQ:KTWO) last released its quarterly earnings results on Tuesday, August 1st. The medical device company reported ($0.21) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.22) by $0.01. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. The firm had revenue of $65.70 million during the quarter, compared to analyst estimates of $66.26 million. During the same period in the previous year, the company posted ($0.27) EPS. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year.
A number of analysts have weighed in on KTWO shares. JMP Securities restated an “outperform” rating and issued a $30.00 price target (up from $27.00) on shares of K2M Group Holdings in a research note on Wednesday, June 28th. Oppenheimer Holdings, Inc. restated a “buy” rating on shares of K2M Group Holdings in a research note on Tuesday, July 11th. Cowen and Company restated a “buy” rating and issued a $26.00 price target on shares of K2M Group Holdings in a research note on Wednesday, July 19th. BidaskClub upgraded K2M Group Holdings from a “hold” rating to a “buy” rating in a research note on Wednesday, July 19th. Finally, Royal Bank Of Canada restated a “buy” rating and issued a $26.00 price target on shares of K2M Group Holdings in a research note on Thursday, July 20th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have assigned a buy rating to the company. K2M Group Holdings presently has an average rating of “Buy” and an average target price of $25.10.
In other news, insider John Philip Md Kostuik sold 1,332 shares of K2M Group Holdings stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $23.30, for a total transaction of $31,035.60. Following the sale, the insider now owns 200,629 shares in the company, valued at $4,674,655.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Gregory S. Cole sold 2,350 shares of K2M Group Holdings stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $24.08, for a total value of $56,588.00. Following the sale, the chief financial officer now owns 55,158 shares in the company, valued at approximately $1,328,204.64. The disclosure for this sale can be found here. Insiders have sold 44,129 shares of company stock worth $1,033,644 in the last quarter. Insiders own 5.80% of the company’s stock.
Institutional investors and hedge funds have recently bought and sold shares of the company. BNP Paribas Arbitrage SA grew its holdings in shares of K2M Group Holdings by 5,175.3% during the second quarter. BNP Paribas Arbitrage SA now owns 4,484 shares of the medical device company’s stock worth $109,000 after buying an additional 4,399 shares during the last quarter. Rockefeller Financial Services Inc. purchased a new position in shares of K2M Group Holdings during the third quarter worth about $105,000. Legal & General Group Plc grew its holdings in shares of K2M Group Holdings by 9.1% during the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock worth $138,000 after buying an additional 564 shares during the last quarter. Dorsey & Whitney Trust CO LLC purchased a new position in shares of K2M Group Holdings during the second quarter worth about $211,000. Finally, Symphony Asset Management LLC purchased a new position in shares of K2M Group Holdings during the second quarter worth about $351,000. Institutional investors and hedge funds own 97.77% of the company’s stock.
Shares of K2M Group Holdings (KTWO) traded up 0.10% on Monday, reaching $20.00. The company had a trading volume of 255,857 shares. The company’s market capitalization is $865.36 million. K2M Group Holdings has a 52 week low of $16.32 and a 52 week high of $25.99. The company has a 50 day moving average of $21.08 and a 200-day moving average of $22.45.
TRADEMARK VIOLATION NOTICE: This news story was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/10/23/zacks-brokerages-expect-k2m-group-holdings-inc-ktwo-will-announce-earnings-of-0-19-per-share.html.
K2M Group Holdings Company Profile
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.